UNIGE document Scientific Article
previous document  unige:112373  next document
add to browser collection
Title

Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study

Authors
Moradpour, Darius
Suter-Riniker, Franziska
Lüthi, Alexander
Cavassini, Matthias
Günthard, Huldrych F
show hidden authors show all authors [1 - 15]
Published in Clinical Infectious Diseases. 2017, vol. 64, no. 9, p. 1275-1278
Abstract We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.0 log reduction in HDV RNA, and 14.3% had undetectable HDV VL within 5 years.
Keywords AdultAnti-HIV Agents/therapeutic useCohort StudiesFemaleHIV Infections/complications/drug therapyHepatitis B virus/isolation & purificationHepatitis BChronic/complications/virologyHepatitis D/virologyHepatitis Delta Virus/drug effects/isolation & purification/physiologyHumansMaleMiddle AgedSwitzerlandTenofovir/therapeutic useViral LoadVirus Replication/drug effects
Identifiers
PMID: 28199492
Full text
Article (Published version) (888 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group VIH/SIDA (930)
Citation
(ISO format)
BEGUELIN, Charles et al. Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study. In: Clinical Infectious Diseases, 2017, vol. 64, n° 9, p. 1275-1278. doi: 10.1093/cid/cix125 https://archive-ouverte.unige.ch/unige:112373

160 hits

0 download

Update

Deposited on : 2018-12-18

Export document
Format :
Citation style :